Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $62.82 and traded as low as $60.41. Novozymes A/S shares last traded at $61.42, with a volume of 217,273 shares traded.
Novozymes A/S Stock Up 1.1%
The company has a debt-to-equity ratio of 0.26, a current ratio of 1.61 and a quick ratio of 1.00. The stock has a market capitalization of $28.76 billion, a P/E ratio of 36.34, a PEG ratio of 1.12 and a beta of 1.10. The stock’s fifty day moving average is $63.01 and its two-hundred day moving average is $62.82.
Novozymes A/S Company Profile
Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.
The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).
Further Reading
- Five stocks we like better than Novozymes A/S
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.
